Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Toshiba's new open-bore MR system receives FDA clearance

Toshiba America Medical Systems : 29 January, 2008  (New Product)
Toshiba America Medical Systems has received FDA clearance for the company's new open-bore 1.5T Vantage Titan MR system.
Following the FDA clearance Toshiba is on schedule to make the system commercially available in the first quarter of 2008.

The open-bore of the Vantage Titan is 18 percent larger than other 1.5T systems on the market, featuring a large 71cm patient aperture.

'Toshiba's Vantage Titan is now one of the most powerful MR units available with a 30/130 gradient platform,' said Bob Giegerich, director, MR Business Unit, Toshiba. 'It is a dramatic improvement over traditional open-bore 1.5T MR systems and offers the largest and widest bore available with a significant reduction in noise.'

The Vantage Titan has a large clinical field-of-view for its bore size and produces high-quality images without compromising homogeneity or overall imaging performance. The system also features Toshiba's patented Pianissimo noise reduction technology, which creates a better imaging experience for all patients.

The Vantage Titan MR system also takes advantage of Toshiba's proprietary, contrast-free MRA techniques Fresh Blood Imaging (FBI), Contrast-free Improved Angiography (CIA), Time-Spatial Labelling Inversion Pulse (Time-SLIP) and Time-Slip Angiography (TSA).

Contrast-free imaging is important because gadolinium, the most common contrast agent used for Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) exams, has been directly linked to a sometimes fatal disease that occurs in patients with renal insufficiency, called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD).

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo